Holen Sie sich die Stockscreener-App
2.85
5.00%
-0.15
Handel nachbörslich:
2.98
0.13
+4.56%
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
22.90%
19.07
|
24.73 | 17.96 | 24.70 | 20.51 |
| Operating Income/Loss |
22.90%
-19.07
|
-24.73 | -17.96 | - | -20.51 |
| Income/Loss From Continuing Operations Before Tax |
55.66%
-17.46
|
-11.22 | -6.495 | -44.19 | 76.97 |
| Income/Loss From Continuing Operations After Tax |
55.66%
-17.46
|
-11.22 | -6.495 | -44.62 | 76.97 |
|
Net Income/Loss
|
55.66%
-17.46
|
-11.22 | -6.495 | -44.62 | 76.97 |
| Preferred Stock Dividends And Other Adjustments |
-1.329
|
- | - | -2.882 | 22.54 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
77.16
|
77.16 | 77.13 | 7.1007 | 51.95 |
| Diluted Average Shares |
0.00%
77.16
|
77.16 | 77.13 | 5.437 | 55.48 |
| Basic Earnings Per Share |
61.54%
-0.21
|
-0.13 | -0.08 | -0.88 | 1.05 |
| Diluted Earnings Per Share |
61.54%
-0.21
|
-0.13 | -0.08 | 0.67 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-1.329
|
- | - | -5.764 | 45.08 |
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):